News
Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate ...
Flagship Biosciences and Advanced Cell Diagnostics collaborate to develop quantitative RNAscope ® assays for pharmaceutical clinical trials in the CLIA environment. The increasing use of RNA ISH in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback